Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Acute and Chronic High-Intensity Exercise Differentially Regulate the miRNA Biogenesis Pathway in Human Skeletal Muscle.

Genes·2026
Same author

Correction: Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same author

Irisin promotes selective changes in hippocampal mitochondrial metabolism in mice.

Biochemistry and biophysics reports·2026
Same author

Dementia and cognitive decline in Black Brazilians: a narrative review.

Frontiers in human neuroscience·2026
Same author

Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same author

Single-nucleus transcriptomics identifies a shared vulnerable excitatory neuronal population across typical and atypical Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Beatriz Ramos Lucente1, Isadora Cristina Ribeiro2, Luis E Santos3

  • 1UNICAMP, Jundiaí, São Paulo, Brazil.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

关键阿尔茨海默氏症风险因素APOE ε4基因对脑脊液 (CSF) 的粉样蛋白水平有影响,但对轻度认知障碍或主观认知衰退的个体的血生物标志物没有影响.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 遗传学 是一个遗传学.
  • 生物标志物研究 生物标志物研究

背景情况:

  • 阿尔茨海默病 (AD) 是最常见的神经退行性疾病.
  • APOE ε4等位基因是散发性AD的主要遗传风险因素.
  • 在早期认知衰退阶段,APOE ε4对粉样β (Aβ) 和陶水平的影响尚不清楚.

研究的目的:

  • 研究APOE基因型与血和CSF生物标志物 (Aβ40,Aβ42,p-tau181,t-tau) 的水平之间的关联.
  • 确定APOE基因型是否影响轻度认知障碍 (MCI) 和主观认知衰退 (SCD) 患者的生物标志物度.

主要方法:

  • 分析了来自64名老年人的血和脑液样本 (MCI,SCD,AD,对照).
  • 使用电化学发光和SIMOA免疫测试量化Aβ42,Aβ40,p-tau181和t-tau.
  • 通过SNP分析确定APOE基因型,并使用Bonferroni校正的ANOVA评估生物标记差异.

主要成果:

  • 与e2ε3基因型相比,具有APOE ε3ε4基因型的个体表现出较低的CSF Aβ42度 (p=0.02).
  • 在APOE基因型之间没有观察到血Aβ40,Aβ42,p-tau181或t-tau水平的显著差异.

结论:

  • 在这个队列中,APOE基因型不会影响外围AD生物标志物水平.
  • APOE ε4等位基因与中枢神经系统粉样蛋白水平的变化有关,特别是中枢神经液Aβ42.2的降低.
  • 研究结果证实了APOE ε4在调节中央粉样蛋白病理中的作用,即使是在早期认知衰退阶段.